Research tools
Analyst Ratings Screener
Find recent upgrades, downgrades, initiations, and reiterations by firm, rating, consensus, target upside, sector, and company size.
Save your best screens
Sign in to keep filters and sorting ready for your next visit.
3,844 matching rating changes
Export CSV| Date, sort lowest first | Symbol | Company | Firm | Action | Prior rating | New rating | Consensus | Analysts, sort highest first | Avg. target | Target upside, sort highest first | Market cap, sort highest first |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | PHR | Phreesia, Inc. | RBC Capital | Reiterated | Outperform | Outperform | — | — | $30.56 | +196.41% | 961.63M |
| Sep 3, 2026 | PHR | Phreesia, Inc. | Wells Fargo | Main | Equal-Weight | Equal-Weight | — | — | $30.56 | +196.41% | 961.63M |
| Sep 3, 2026 | PHR | Phreesia, Inc. | Canaccord Genuity | Main | Buy | Buy | — | — | $30.56 | +196.41% | 961.63M |
| Sep 3, 2026 | PHR | Phreesia, Inc. | Needham | Reiterated | Buy | Buy | — | — | $30.56 | +196.41% | 961.63M |
| Sep 3, 2026 | PLTK | Playtika Holding Corp. | Citigroup | Main | Buy | Buy | — | — | $3.75 | +62.34% | 1.61B |
| Sep 3, 2026 | PR | Permian Resources Corporation | Seaport Global | Initiated | — | Buy | — | — | $20.33 | -14.51% | 10.35B |
| Sep 3, 2026 | PSX | Phillips 66 | Piper Sandler | Main | Neutral | Neutral | Buy | 15 | $134.80 | -48.05% | 57.77B |
| Sep 3, 2026 | PVH | PVH Corp. | JP Morgan | Main | Underweight | Underweight | — | — | $100.33 | +42.03% | 3.72B |
| Sep 3, 2026 | PVH | PVH Corp. | Needham | Main | Buy | Buy | — | — | $100.33 | +42.03% | 3.72B |
| Sep 3, 2026 | RARE | Ultragenyx Pharmaceutical Inc. | Wells Fargo | Main | Overweight | Overweight | — | — | $50.00 | +249.65% | 3.49B |
| Sep 3, 2026 | RARE | Ultragenyx Pharmaceutical Inc. | Wedbush | Main | Neutral | Neutral | — | — | $50.00 | +249.65% | 3.49B |
| Sep 3, 2026 | RARE | Ultragenyx Pharmaceutical Inc. | Canaccord Genuity | Main | Buy | Buy | — | — | $50.00 | +249.65% | 3.49B |
| Sep 3, 2026 | RARE | Ultragenyx Pharmaceutical Inc. | Evercore ISI Group | Downgrade | Outperform | In-Line | — | — | $50.00 | +249.65% | 3.49B |
| Sep 3, 2026 | RARE | Ultragenyx Pharmaceutical Inc. | Baird | Downgrade | Outperform | Neutral | — | — | $50.00 | +249.65% | 3.49B |
| Sep 3, 2026 | RARE | Ultragenyx Pharmaceutical Inc. | HC Wainwright & Co. | Main | Buy | Buy | — | — | $50.00 | +249.65% | 3.49B |
| Sep 3, 2026 | RARE | Ultragenyx Pharmaceutical Inc. | Cantor Fitzgerald | Main | Overweight | Overweight | — | — | $50.00 | +249.65% | 3.49B |
| Sep 3, 2026 | RARE | Ultragenyx Pharmaceutical Inc. | Jefferies | Main | Buy | Buy | — | — | $50.00 | +249.65% | 3.49B |
| Sep 3, 2026 | RARE | Ultragenyx Pharmaceutical Inc. | William Blair | Downgrade | Outperform | Market Perform | — | — | $50.00 | +249.65% | 3.49B |
| Sep 3, 2026 | RARE | Ultragenyx Pharmaceutical Inc. | JP Morgan | Downgrade | Overweight | Neutral | — | — | $50.00 | +249.65% | 3.49B |
| Sep 3, 2026 | RARE | Ultragenyx Pharmaceutical Inc. | TD Cowen | Main | Buy | Buy | — | — | $50.00 | +249.65% | 3.49B |
| Sep 3, 2026 | RARE | Ultragenyx Pharmaceutical Inc. | Citigroup | Main | Buy | Buy | — | — | $50.00 | +249.65% | 3.49B |
| Sep 3, 2026 | RNG | RingCentral, Inc. | RBC Capital | Initiated | — | Outperform | — | — | $33.00 | -52.12% | 2.81B |
| Sep 3, 2026 | SATA | Strive, Inc. Variable Rate Series A Perpetual Preferred Stock | B. Riley Securities | Main | Buy | Buy | Buy | 5 | — | — | 61.42B |
| Sep 3, 2026 | SGI | Somnigroup International Inc | UBS | Main | Buy | Buy | — | — | $70.00 | +4.85% | 19.8B |
| Sep 3, 2026 | SGI | Somnigroup International Inc | Piper Sandler | Reiterated | Overweight | Overweight | — | — | $70.00 | +4.85% | 19.8B |
| Sep 3, 2026 | SM | SM Energy Company | Seaport Global | Initiated | — | Sell | — | — | $29.17 | -23.44% | 2.27B |
| Sep 3, 2026 | SNOW | Snowflake Inc. | Morgan Stanley | Main | Overweight | Overweight | Buy | 39 | $282.25 | -14.21% | 73.81B |
| Sep 3, 2026 | SNOW | Snowflake Inc. | RBC Capital | Main | Outperform | Outperform | Buy | 39 | $282.25 | -14.21% | 73.81B |
| Sep 3, 2026 | SNOW | Snowflake Inc. | Wells Fargo | Main | Overweight | Overweight | Buy | 39 | $282.25 | -14.21% | 73.81B |
| Sep 3, 2026 | SNOW | Snowflake Inc. | DA Davidson | Main | Buy | Buy | Buy | 39 | $282.25 | -14.21% | 73.81B |
| Sep 3, 2026 | SNOW | Snowflake Inc. | Stifel | Main | Buy | Buy | Buy | 39 | $282.25 | -14.21% | 73.81B |
| Sep 3, 2026 | SNOW | Snowflake Inc. | Oppenheimer | Main | Outperform | Outperform | Buy | 39 | $282.25 | -14.21% | 73.81B |
| Sep 3, 2026 | SNOW | Snowflake Inc. | Barclays | Main | Equal-Weight | Equal-Weight | Buy | 39 | $282.25 | -14.21% | 73.81B |
| Sep 3, 2026 | SNOW | Snowflake Inc. | Guggenheim | Reiterated | Neutral | Neutral | Buy | 39 | $282.25 | -14.21% | 73.81B |
| Sep 3, 2026 | SNOW | Snowflake Inc. | Canaccord Genuity | Main | Buy | Buy | Buy | 39 | $282.25 | -14.21% | 73.81B |
| Sep 3, 2026 | SNOW | Snowflake Inc. | Rosenblatt | Main | Buy | Buy | Buy | 39 | $282.25 | -14.21% | 73.81B |
| Sep 3, 2026 | SNOW | Snowflake Inc. | Citizens | Main | Market Outperform | Market Outperform | Buy | 39 | $282.25 | -14.21% | 73.81B |
| Sep 3, 2026 | SNOW | Snowflake Inc. | Cantor Fitzgerald | Main | Overweight | Overweight | Buy | 39 | $282.25 | -14.21% | 73.81B |
| Sep 3, 2026 | SNOW | Snowflake Inc. | Needham | Main | Buy | Buy | Buy | 39 | $282.25 | -14.21% | 73.81B |
| Sep 3, 2026 | SNOW | Snowflake Inc. | BTIG | Main | Buy | Buy | Buy | 39 | $282.25 | -14.21% | 73.81B |
| Sep 3, 2026 | SNOW | Snowflake Inc. | JP Morgan | Main | Overweight | Overweight | Buy | 39 | $282.25 | -14.21% | 73.81B |
| Sep 3, 2026 | SNOW | Snowflake Inc. | Jefferies | Main | Buy | Buy | Buy | 39 | $282.25 | -14.21% | 73.81B |
| Sep 3, 2026 | SNOW | Snowflake Inc. | UBS | Main | Buy | Buy | Buy | 39 | $282.25 | -14.21% | 73.81B |
| Sep 3, 2026 | SNOW | Snowflake Inc. | StoneX | Main | Buy | Buy | Buy | 39 | $282.25 | -14.21% | 73.81B |
| Sep 3, 2026 | SNOW | Snowflake Inc. | TD Cowen | Main | Buy | Buy | Buy | 39 | $282.25 | -14.21% | 73.81B |
| Sep 3, 2026 | SNOW | Snowflake Inc. | Citigroup | Main | Buy | Buy | Buy | 39 | $282.25 | -14.21% | 73.81B |
| Sep 3, 2026 | SNOW | Snowflake Inc. | Truist Securities | Reiterated | Buy | Buy | Buy | 39 | $282.25 | -14.21% | 73.81B |
| Sep 3, 2026 | SNOW | Snowflake Inc. | Evercore ISI Group | Main | Outperform | Outperform | Buy | 39 | $282.25 | -14.21% | 73.81B |
| Sep 3, 2026 | SNOW | Snowflake Inc. | Piper Sandler | Reiterated | Overweight | Overweight | Buy | 39 | $282.25 | -14.21% | 73.81B |
| Sep 3, 2026 | SNOW | Snowflake Inc. | Raymond James | Main | Outperform | Outperform | Buy | 39 | $282.25 | -14.21% | 73.81B |
